N, B., A, I., & CM, D. (2023). Treatment response in hemato-oncology in the context of the German early benefit assessment of drugs compared to clinical practice. Journal of evidence-based medicine, 16(4), 451. https://doi.org/10.1111/jebm.12575
Chicago Style (17th ed.) CitationN, Baltes, Icks A, and Dintsios CM. "Treatment Response in Hemato-oncology in the Context of the German Early Benefit Assessment of Drugs Compared to Clinical Practice." Journal of Evidence-based Medicine 16, no. 4 (2023): 451. https://doi.org/10.1111/jebm.12575.
MLA (9th ed.) CitationN, Baltes, et al. "Treatment Response in Hemato-oncology in the Context of the German Early Benefit Assessment of Drugs Compared to Clinical Practice." Journal of Evidence-based Medicine, vol. 16, no. 4, 2023, p. 451, https://doi.org/10.1111/jebm.12575.